Supplemental material for An adaptive design for the identification of the optimal dose using joint modeling of continuous repeated biomarker measurements and time-to-toxicity in phase I/II clinical trials in oncology

Supplemental Material for An adaptive design for the identification of the optimal dose using joint modeling of continuous repeated biomarker measurements and time-to-toxicity in phase I/II clinical trials in oncology by Maria-Athina Altzerinakou and Xavier Paoletti in Statistical Methods in Medical Research